LQDA Collar Strategy
LQDA (Liquidia Corporation), in the Healthcare sector, (Medical - Pharmaceuticals industry), listed on NASDAQ.
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
LQDA (Liquidia Corporation) trades in the Healthcare sector, specifically Medical - Pharmaceuticals, with a market capitalization of approximately $5.17B, a beta of 0.54 versus the broader market, a 52-week range of 22.31-93.61, average daily share volume of 3.0M, a public-listing history dating back to 2018, approximately 216 full-time employees. These structural characteristics shape how LQDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.54 indicates LQDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on LQDA?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
LQDA snapshot
As of November 13, 2026, spot at $57.77, ATM IV 64.47%, IV rank 0.00%, expected move 18.48%. The collar on LQDA below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this collar structure on LQDA specifically: IV regime affects collar pricing on both sides; compressed LQDA IV at 64.47% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 18.48% (roughly $10.68 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LQDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on LQDA should anchor to the underlying notional of $57.77 per share and to the trader's directional view on LQDA stock.
LQDA collar setup
The LQDA collar below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LQDA at $57.77 on that close, the first option leg uses a $61.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LQDA chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LQDA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $57.77 | long |
| Sell 1 | Call | $61.00 | $3.35 |
| Buy 1 | Put | $55.00 | $2.28 |
LQDA collar risk and reward
- Net Premium / Debit
- -$5,669.50
- Max Profit (per contract)
- $430.50
- Max Loss (per contract)
- -$169.50
- Breakeven(s)
- $56.70
- Risk / Reward Ratio
- 2.540
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
LQDA collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on LQDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$169.50 |
| $12.78 | -77.9% | -$169.50 |
| $25.55 | -55.8% | -$169.50 |
| $38.33 | -33.7% | -$169.50 |
| $51.10 | -11.5% | -$169.50 |
| $63.87 | +10.6% | +$430.50 |
| $76.64 | +32.7% | +$430.50 |
| $89.42 | +54.8% | +$430.50 |
| $102.19 | +76.9% | +$430.50 |
| $114.96 | +99.0% | +$430.50 |
When traders use collar on LQDA
Collars on LQDA hedge an existing long LQDA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
LQDA thesis for this collar
The market-implied 1-standard-deviation range for LQDA extends from approximately $47.09 on the downside to $68.45 on the upside. A LQDA collar hedges an existing long LQDA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current LQDA IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LQDA at 64.47%. As a Healthcare name, LQDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LQDA-specific events.
LQDA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LQDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LQDA alongside the broader basket even when LQDA-specific fundamentals are unchanged. Always rebuild the position from current LQDA chain quotes before placing a trade.
Frequently asked questions
- What is a collar on LQDA?
- A collar on LQDA is the collar strategy applied to LQDA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With LQDA stock at $57.77 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed LQDA chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LQDA collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the LQDA collar priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 64.47%), the computed maximum profit is $430.50 per contract and the computed maximum loss is -$169.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LQDA collar?
- The breakeven for the LQDA collar priced on this page is roughly $56.70 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LQDA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 18.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on LQDA?
- Collars on LQDA hedge an existing long LQDA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current LQDA implied volatility affect this collar?
- LQDA ATM IV is at 64.47% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.